Cargando…
Predictive and Prognostic Implications of Circulating CX3CR1(+) CD8(+) T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy
Lack of reliable predictive biomarkers is a major limitation of combination therapy with chemotherapy and anti–programmed cell death protein 1/programmed death-ligand 1 (anti-PD-1/PD-L1) therapy (chemo-immunotherapy). We previously observed that the increase of peripheral blood CD8(+) T cells expres...
Autores principales: | Abdelfatah, Eihab, Long, Mark D., Kajihara, Ryutaro, Oba, Takaaki, Yamauchi, Takayoshi, Chen, Hongbin, Sarkar, Joy, Attwood, Kristopher, Matsuzaki, Junko, Segal, Brahm H., Dy, Grace K., Ito, Fumito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060186/ https://www.ncbi.nlm.nih.gov/pubmed/37009132 http://dx.doi.org/10.1158/2767-9764.CRC-22-0383 |
Ejemplares similares
-
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
por: Yamauchi, Takayoshi, et al.
Publicado: (2021) -
Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy
por: Sarkar, Joy, et al.
Publicado: (2023) -
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer
por: Yokoi, Toshihiro, et al.
Publicado: (2021) -
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling
por: Makino, Kenichi, et al.
Publicado: (2022) -
CX3CR1 in multiple sclerosis
por: Rivest, Serge
Publicado: (2015)